Financhill
Sell
35

MED Quote, Financials, Valuation and Earnings

Last price:
$16.87
Seasonality move :
-3.81%
Day range:
$16.73 - $17.47
52-week range:
$16.73 - $70.58
Dividend yield:
0%
P/E ratio:
27.74x
P/S ratio:
0.27x
P/B ratio:
0.89x
Volume:
482.5K
Avg. volume:
230.5K
1-year change:
-74.75%
Market cap:
$185.1M
Revenue:
$1.1B
EPS (TTM):
$0.61

Earnings Data

Next earnings date for MED
Feb 20
2025
Most recent earnings per share
$0.10
Beat by $0.29
(Nov 4/2024)
Consensus Estimate
-$0.19
(Nov 4/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MED Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/20/2025 Q4 $114.3M -- -- -$0.16 --
11/04/2024 Q3 $138.2M $140.2M $0.10 -$0.19 $0.29
08/05/2024 Q2 $174.1M $168.6M -$0.75 $0.39 -$1.14
04/29/2024 Q1 $173.5M $174.7M $0.76 $0.80 -$0.04
02/20/2024 Q4 $184.2M $191M $0.50 $0.96 -$0.46
11/06/2023 Q3 -- -- $2.12 $1.07 $1.06
08/07/2023 Q2 -- -- $2.77 $1.44 $1.33
05/01/2023 Q1 -- -- $3.67 $2.40 $1.27
02/21/2023 Q4 -- -- $2.43 $2.22 $0.21
11/03/2022 Q3 -- -- $3.27 $1.91 $1.36
08/03/2022 Q2 -- -- $3.42 $3.23 $0.19
05/02/2022 Q1 -- -- $3.59 $3.57 $0.02
02/23/2022 Q4 -- -- $2.91 $2.65 $0.26
11/04/2021 Q3 -- -- $3.56 $2.92 $0.64
08/04/2021 Q2 -- -- $3.96 $3.30 $0.66
05/04/2021 Q1 -- -- $3.46 $2.72 $0.74
02/25/2021 Q4 -- -- $2.36 $2.36 -$0.00
11/02/2020 Q3 -- -- $2.91 $2.49 $0.42
08/05/2020 Q2 -- -- $1.86 $1.84 $0.02
05/05/2020 Q1 -- -- $1.56 $1.32 $0.25
02/26/2020 Q4 -- -- $1.66 $1.08 $0.58
11/07/2019 Q3 -- -- $1.32 $1.33 -$0.00
08/01/2019 Q2 -- -- $1.75 $1.72 $0.03
05/01/2019 Q1 -- -- $1.70 $1.53 $0.17
02/26/2019 Q4 -- -- $1.30 $1.20 $0.11
11/06/2018 Q3 -- -- $1.14 $1.14 --
08/02/2018 Q2 -- -- $1.16 $0.98 $0.18
05/03/2018 Q1 -- -- $1.01 -- --
03/06/2018 Q4 -- -- $0.60 -- --
11/07/2017 Q3 -- -- $0.55 -- --
08/08/2017 Q2 -- -- $0.63 -- --
05/04/2017 Q1 -- -- $0.51 -- --
03/09/2017 Q4 -- -- $0.34 -- --
11/03/2016 Q3 -- -- $0.51 -- --
08/03/2016 Q2 -- -- $0.29 -- --
05/04/2016 Q1 -- -- $0.36 -- --
03/10/2016 Q4 -- -- $0.33 -- --
11/05/2015 Q3 -- -- $0.46 -- --
08/05/2015 Q2 -- -- $0.51 -- --
05/07/2015 Q1 -- -- $0.36 -- --
03/12/2015 Q4 -- -- -$0.28 -- --

Medifast Earnings Questions

  • How Much did Medifast Generate in Revenue Last Quarter?

    Medifast reported $140.2M worth of top line sales in its most recent quarter.

  • Did Medifast Beat Earnings Last Quarter?

    Medifast announced earnings per share of $0.10 which represents a beat of analyst forecast a -$0.19 per share.

  • Is Medifast Profitable?

    Medifast reported $105.7M that represents $9.63 per share over the last quarter.

  • What is the Analyst Consensus for Medifast EPS Next Year?

    Medifast's earnings are forecast to decrease from $9.10 per share to $9.52 per share next year representing a decrease of -80.55%.

  • When is Medifast's Earnings Date?

    Medifast's next earnings date is February 20, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock